Latest In: Lennox-Gastaut syndrome

cannabidiol cbd Dravet syndrome Epidiolex FDA GW Pharmaceuticals Lennox-Gastaut syndrome tuberous sclerosis complex U.S. Food and Drug Administration

FDA approves GW Pharmaceuticals’ cannabis drug for new indication

CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a…

News August 3
Cesamet Dravet syndrome Epidiolex Lennox-Gastaut syndrome Marinol Ministry of Food and Drug Safety multiple sclerosis Sativex Singapore South Korea

South Korea’s medical cannabinoid law to go into effect in March

A groundbreaking law legalizing medical cannabis in South Korea that takes effect March 12 will pave the way for the…

News February 19
MJBizCon Logo